LSC Recent Webinars on BIO

  1. OneTeam™: Setting A New Standard for Biotech Program Visibility 4/15/2026

    An on‑demand session showing how integrated governance and real‑time data boost visibility, collaboration, and control in outsourced gene therapy development.

  2. Less Risk, More Speed -The New Blueprint For Bioconjugate Development 4/15/2026

    A fireside chat on how integrated development models reduce risk and accelerate bioconjugate timelines from discovery through GMP manufacturing.

  3. Industrializing Cell Therapy With Perfusion 4/14/2026

    Explore how intensified perfusion strategies enable rapid, high‑density CAR‑T expansion, predictive scale‑down modeling, and efficient automated harvest, supporting shorter timelines and higher yields.

  4. Defined Media, Defined Results: Scaling E. coli From Bench To Fermenter 4/9/2026

    Understand the benefits of chemically defined media in E. coli systems, explore real-world plasmid DNA data, and learn practical strategies for scaling to robust manufacturing.

  5. Digital Design Meets Proven Performance: The Future Of Single-Use Assemblies 3/31/2026

    Single-use assembly design is evolving fast. Learn how scalable platforms, digital automation tools, and global supply networks are converging to support sustainable biopharma manufacturing at scale.

  6. Applying AI And Rapid Prototyping To Media And Process Development 3/26/2026

    Hear from industry experts on how teams can integrate manufacturability considerations earlier through rapid prototyping, data-driven media development, and predictive modeling.

  7. 2026 Manufacturing Trends Reshaping Life Sciences 3/26/2026

    Explore the manufacturing trends shaping 2026, from AI in validated environments to connected systems and digital workforce readiness that are building more agile, resilient, and compliant operations.

  8. Strategies To Modernize Asset Performance In Manufacturing 3/24/2026

    Learn how to advance from reactive maintenance to predictive, data-driven operations, as well as about APM maturity stages, common transformation challenges, and practical steps to improve reliability.

  9. Flexible Therapeutic Development: Balancing Speed, Cost, and Process 3/24/2026

    Microbial development for first‑in‑human studies requires coordinated cell line, fermentation, and purification strategies to accelerate timelines while controlling cost and process robustness.

  10. Accelerating Vector Construction-To-IND: Achieving A 9-Month Timeline Through Integrated Cell Line Development 3/19/2026

    Uncover how tighter alignment between vector construction and cell banking improved development efficiency, strengthened risk management, and enhanced early-stage program outcomes.